Home

Taro Pharmaceutical Industries Ltd. Ordinary Shares (TARO)

42.97
+0.00 (0.00%)
NYSE · Last Trade: Jun 9th, 11:27 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
TARO Stock Earnings: Taro Pharmaceutical Indus Reported Results for Q4 2024investorplace.com
Taro Pharmaceutical Indus just reported results for the fourth quarter of 2024.
Via InvestorPlace · May 20, 2024
Earnings Scheduled For October 26, 2023benzinga.com
Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on revenue of $49.83 billion.
Via Benzinga · October 26, 2023
Taro Pharmaceutical Indus Earnings Previewbenzinga.com
Via Benzinga · October 25, 2023
Why Shares of Taro Pharmaceutical Are Rising Tuesdayfool.com
The company is mulling a buyout offer from Sun Pharmaceutical.
Via The Motley Fool · May 30, 2023
Stocks That Hit 52-Week Lows On Wednesdaybenzinga.com
  On Wednesday, 479 stocks made new 52-week lows.
Via Benzinga · March 15, 2023
Taro Pharmaceutical Indus's Earnings Outlookbenzinga.com
Via Benzinga · January 23, 2023
Earnings Scheduled For January 25, 2024benzinga.com
Companies Reporting Before The Bell • Nokia (NYSE:NOK) is projected to report quarterly earnings at $0.15 per share on revenue of $7.05 billion.
Via Benzinga · January 25, 2024
Earnings Preview For Taro Pharmaceutical Indusbenzinga.com
Via Benzinga · January 24, 2024
Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com
Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.
Via Benzinga · May 30, 2023
Taro Pharmaceutical Indus's Earnings: A Previewbenzinga.com
Taro Pharmaceutical Indus (NYSE:TARO) is set to give its latest quarterly earnings report on Thursday, 2022-10-27. Here's what investors need to know before the announcement. Analysts estimate that Taro Pharmaceutical Indus will report an earnings per share (EPS) of $0.84.
Via Benzinga · October 26, 2022
Taro Pharmaceutical Indus: Q1 Earnings Insightsbenzinga.com
Taro Pharmaceutical Indus (NYSE:TARO) reported its Q1 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via Benzinga · July 27, 2022
Earnings Scheduled For January 24, 2023benzinga.com
Companies Reporting Before The Bell • GATX (NYSE:GATX) is expected to report quarterly earnings at $1.44 per share on revenue of $327.63 million.
Via Benzinga · January 24, 2023
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapybenzinga.com
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via Benzinga · July 27, 2022
Earnings Scheduled For October 27, 2022benzinga.com
Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million.
Via Benzinga · October 27, 2022
Stocks That Hit 52-Week Lows On Mondaybenzinga.com
  On Monday, 429 stocks made new 52-week lows.
Via Benzinga · September 19, 2022
Earnings Scheduled For July 27, 2022benzinga.com
  Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.
Via Benzinga · July 27, 2022
Stocks That Hit 52-Week Lows On Thursdaybenzinga.com
  On Thursday, 94 companies set new 52-week lows.
Via Benzinga · May 26, 2022
Taro Pharmaceutical Indus Earnings Previewbenzinga.com
Taro Pharmaceutical Indus (NYSE:TARO) is set to give its latest quarterly earnings report on Thursday, 2022-05-26. Here's what investors need to know before the announcement. Analysts estimate that Taro Pharmaceutical Indus will report an earnings per share (EPS) of $0.88.
Via Benzinga · May 25, 2022
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & Morebenzinga.com
Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.
Via Benzinga · May 22, 2022
Earnings Scheduled For May 26, 2022benzinga.com
  Companies Reporting Before The Bell • American Woodmark (NASDAQ:AMWD) is likely to report quarterly earnings at $1.34 per share on revenue of $493.20 million.
Via Benzinga · May 26, 2022
10 Biggest Price Target Changes For Mondaybenzinga.com
Keybanc cut the price target on The Sherwin-Williams Company (NYSE: SHW) from $394 to $335. Sherwin-Williams shares rose 1.6% to close at $287.70 on Friday.
Via Benzinga · January 31, 2022
Stocks That Hit 52-Week Lows On Fridaybenzinga.com
  On Friday, 213 companies hit new 52-week lows.
Via Benzinga · April 29, 2022
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicronbenzinga.com
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via Benzinga · January 28, 2022
Taro Pharmaceutical: Q3 Earnings Insightsbenzinga.com
  Taro Pharmaceutical Indus (NYSE:TARO) reported its Q3 earnings results on Thursday, January 27, 2022 at 04:00 PM. Here's what investors need to know about the...
Via Benzinga · January 28, 2022
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Studybenzinga.com
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via Benzinga · January 27, 2022